| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Sinclair Andrew is a Director at Adicet Bio, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $699K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29, 2022 | SLNO Soleno Therapeutics Inc | Director | Buy | 7,720,000 | $0.00 | - | +74.9% | -19.7% | -31.2% | |
| Dec 8, 2021 | ACET Adicet Bio, Inc. | Director | Buy | 500,000 | $14.00 | $7,000,000.00 | +30.5% | -14.5% | +30.0% | |
| Jun 26, 2020 | SLNO Soleno Therapeutics Inc | Director | Buy | 3,333,330 | $1.65 | $5,499,994.50 | +47.8% | - | - | |
| Oct 25, 2019 | SLNO Soleno Therapeutics Inc | Director | Buy | 2,300,000 | $1.20 | $2,760,000.00 | +49.3% | - | - | |
| Dec 21, 2018 | SLNO Soleno Therapeutics Inc | Director | Buy | 4,669,272 | $1.60 | $7,470,835.20 | New | - | - |